Evidence map›Paper›PMID 32963560›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Jingui Shenqi Pills Regulate Bone-Fat Balance in Murine Ovariectomy-Induced Osteoporosis with Kidney Yang Deficiency.

Qi Shang, Wenhua Zhao, Gengyang Shen, Xiang Yu, Zhida Zhang, Xuan Huang, Weicheng Qin, Guifeng Chen, Fuyong Yu, Kai Tang and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Poricoic acid A attenuates renal fibrosis by inhibiting endoplasmic reticulum stress-mediated apoptosis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Qi ShangGuangzhou University of Chinese Medicine, Guangzhou 510405, China.ORCID https://orcid.org/0000-0001-9135-2666
Wenhua ZhaoGuangzhou University of Chinese Medicine, Guangzhou 510405, China.
Gengyang ShenLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Xiang YuLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Zhida ZhangGuangzhou University of Chinese Medicine, Guangzhou 510405, China.
Xuan HuangGuangzhou University of Chinese Medicine, Guangzhou 510405, China.
Weicheng QinGuangzhou University of Chinese Medicine, Guangzhou 510405, China.
Guifeng ChenGuangzhou University of Chinese Medicine, Guangzhou 510405, China.
Fuyong YuGuangzhou University of Chinese Medicine, Guangzhou 510405, China.
Kai TangGuangzhou University of Chinese Medicine, Guangzhou 510405, China.
Honglin ChenLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Juanmin LiLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
De LiangLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Jingjing TangLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.ORCID https://orcid.org/0000-0002-4339-4789
Xiaobing JiangLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.ORCID https://orcid.org/0000-0002-8009-0282
Hui RenLingnan Medical Research Center of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.ORCID https://orcid.org/0000-0003-1698-5505
Guangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Jingui Shenqi Pills (JGSQP) have been a staple of traditional Chinese medicine for thousands of years, used primarily as a treatment for kidney yang deficiency (KYD).

Identifiers

PMID32963560
PMCPMC7492893
OpenAlexW3083613171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.